15o water

Small moleculeexperimentalImaging agent

Clinical trial activity

9 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 1998 (NCT00001783)

Timeline

1990s

  1. Jan 1, 1998

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
15-oxygen

Oral

No

Parenteral

No

Topical

No

Also known as

  • 15o water
  • 15o water
  • 15o-water
  • 15o-water
  • o-15 water

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03388788Early Phase 1 (Phase 1)May 1, 2018Oregon Health and Science University
NCT02789098N/AJun 30, 2016Société Française de Cardiologie, University of Caen-Normandie
NCT02272985N/AApr 30, 2015University of Groningen
NCT01246869Phase 1Mar 27, 2013University of Utah
NCT02608944N/ASep 1, 2012University of Utah
NCT00813566Phase 1Nov 12, 2010University of Utah
NCT00714142Phase 2Aug 1, 2008Proportional Technologies, Inc., University of Wisconsin
NCT00014794Phase 1Apr 1, 2001National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00001783Phase 2Apr 1, 1998National Institute of Neurological Disorders and Stroke (NINDS)
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of UtahAcademic/Hospital3322010
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Government1112001
National Institute of Neurological Disorders and Stroke (NINDS)Government1111998
Oregon Health and Science UniversityAcademic/Hospital1112018
Proportional Technologies, Inc.For profit1112008
Société Française de CardiologieAcademic/Hospital1012016
University of Caen-NormandieAcademic/Hospital1112016
University of GroningenAcademic/Hospital1112015
University of WisconsinAcademic/Hospital1012008
9 organizations
Page 1 / 1